NLRP3 and type 2 diabetes mellitus: Mechanistically, it has been shown that NLRP3 inflammasome-mediated inflammatory responses are activated in T2DM animals with OSA as well as cell models, which may be related to MALT1 overexpression leading to inhibition of miR-224-5p in the hippocampus (Du et al., 2020).